Related Experiment Video
Updated: Nov 10, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?
Masoud Etemadifar1, Nahad Sedaghat2, Ali Aghababaee3
1Department of Neurosurgery, Isfahan University of Medical Sciences, Isfahan, Iran.
Background:
COVID-19 is speculated to increase the likelihood of relapsing-remitting multiple sclerosis (RRMS) exacerbation.
Objective:
To investigate the association between contraction of COVID-19 and incidence of acute MS attacks in RRMS patients six months post-infection.
Methods:
This retrospective cohort study compares the risk of relapse in RRMS patients with (n=56) and without COVID-19 (n=69). Incidence of relapse was recorded for six-month following contraction of COVID-19. Incidence of RRMS exacerbation in patients with COVID-19 was compared to patients without COVID-19 (the independent control group) and the same patients six months prior to the COVID-19 pandemic.
Results:
A lower incidence rate of RRMS exacerbation was observed in patients that contracted COVID-19 than in patients who did not contract COVID-19 (incidence rate ratio: 0.275; p=0.026). Self-controlled analysis showed no significant difference in relapse rates before the COVID-19 pandemic and after contracting COVID-19 (p=0.222). The relapse risk was not different between patients who had been hospitalized due to COVID-19 severity and those who had not (p=0.710).
Conclusion:
COVID-19 contraction may not increase the risk of acute MS attacks shortly following contraction. We hypothesize that COVID-19-associated lymphopenia may partly preclude the autoreactive memory cells from expansion and initiating relapses through a so-called bystander effect of COVID-19 infection.
Insights
COVID-19 infection did not increase the risk of acute attacks in relapsing-remitting multiple sclerosis (RRMS) patients. Lymphopenia from COVID-19 may prevent MS relapses by inhibiting autoreactive cell expansion.
Area of Science:
- Neurology
- Infectious Diseases
- Immunology
Background:
- Speculation exists that COVID-19 may trigger relapsing-remitting multiple sclerosis (RRMS) exacerbations.
- Understanding the impact of COVID-19 on MS is crucial for patient management.
Purpose of the Study:
- To investigate the association between COVID-19 infection and acute Multiple Sclerosis (MS) attacks in RRMS patients within six months post-infection.
- To compare relapse incidence in RRMS patients who contracted COVID-19 versus those who did not.
Main Methods:
- A retrospective cohort study compared RRMS patients with (n=56) and without (n=69) COVID-19.
- Relapse incidence was recorded for six months following COVID-19 contraction.
- RRMS exacerbation incidence was compared between COVID-19 patients, a control group, and pre-pandemic baseline.
Main Results:
- A significantly lower incidence rate of RRMS exacerbation was observed in patients who contracted COVID-19 compared to controls (IRR: 0.275; p=0.026).
- Self-controlled analysis revealed no significant difference in relapse rates before COVID-19 and after infection (p=0.222).
- Hospitalization severity due to COVID-19 did not alter relapse risk (p=0.710).
Conclusions:
- COVID-19 contraction does not appear to elevate the risk of acute MS attacks in the short term.
- Hypothesized mechanism: COVID-19-induced lymphopenia may inhibit autoreactive memory cell expansion, preventing relapses via a bystander effect.
More Related Videos
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Psychological and Sociocultural Causes of Schizophrenia
Bystander Effect
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Vaccinations